Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Stewart Sell. (2019) How vaccines work: immune effector mechanisms and designer vaccines. Expert Review of Vaccines 18:10, pages 993-1015.
Read now
Read now
Franz Zemp, Jahanara Rajwani & Douglas J. Mahoney. (2018) Rhabdoviruses as vaccine platforms for infectious disease and cancer. Biotechnology and Genetic Engineering Reviews 34:1, pages 122-138.
Read now
Read now
Weihua Li, Chuanyun Li, Wei Xia & Xiuhui Li. (2017) HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients. Human Vaccines & Immunotherapeutics 13:10, pages 2341-2347.
Read now
Read now
Articles from other publishers (16)
Yasemin van Heuvel, Stefanie Schatz, Jamila Franca Rosengarten & Jörn Stitz. (2022) Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. Toxins 14:2, pages 138.
Crossref
Crossref
Amit Kumar, Elena E. Giorgi, Joshua J. Tu, David R. Martinez, Joshua Eudailey, Michael Mengual, Manukumar Honnayakanahalli Marichannegowda, Russell Van Dyke, Feng Gao & Sallie R. Permar. (2021) Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers. PLOS Pathogens 17:4, pages e1009478.
Crossref
Crossref
Le Chang, Junpeng Zhao, Fei Guo, Huimin Ji, Lu Zhang, Xinyi Jiang & Lunan Wang. (2021) HIV-1 gp41 genetic diversity and enfuvirtide resistance-associated mutations among enfuvirtide-naïve patients in southern China. Virus Research 292, pages 198215.
Crossref
Crossref
Mona Sadat Larijani, Mohammad Hassan Pouriayevali, Seyed Mehdi Sadat & Amitis Ramezani. (2020) Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles. Current Drug Delivery 17:5, pages 387-395.
Crossref
Crossref
Alan D. CurtisIIII, Maria Dennis, Joshua Eudailey, Korey L. Walter, Kenneth Cronin, S. Munir Alam, Neelima Choudhary, Ryan H. Tuck, Michael Hudgens, Pamela A. Kozlowski, Justin Pollara, Guido Ferrari, Koen K. A. Van Rompay, Sallie Permar & Kristina De Paris. (2020) HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy. mSphere 5:2.
Crossref
Crossref
Bartek Nogal, Matteo Bianchi, Christopher A. Cottrell, Robert N. Kirchdoerfer, Leigh M. Sewall, Hannah L. Turner, Fangzhu Zhao, Devin Sok, Dennis R. Burton, Lars Hangartner & Andrew B. Ward. (2020) Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines. Cell Reports 30:11, pages 3755-3765.e7.
Crossref
Crossref
Marina A. Dobrovolskaia. (2019) Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies. Molecules 24:24, pages 4620.
Crossref
Crossref
Jian Liu, Dabbu Kumar Jaijyan, Qiyi Tang & Hua Zhu. (2019) Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8+ T-Cell Response. International Journal of Molecular Sciences 20:18, pages 4457.
Crossref
Crossref
Julie Boucau & Sylvie Le Gall. (2019) Antigen processing and presentation in HIV infection. Molecular Immunology 113, pages 67-74.
Crossref
Crossref
Rosamund Chapman & Edward P. Rybicki. (2019) Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation. Vaccines 7:2, pages 50.
Crossref
Crossref
Michiel T. van Diepen, Rosamund Chapman, Nicola Douglass, Shireen Galant, Penny L. Moore, Emmanuel Margolin, Phindile Ximba, Lynn Morris, Edward P. Rybicki & Anna-Lise Williamson. (2019) Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus. Journal of Virology 93:8.
Crossref
Crossref
Bikash Sahay, Alek Aranyos, Meerambika Mishra, Andrew McAvoy, Marcus Martin, Riuyu Pu, Sayaka Shiomitsu, Keijiro Shiomitsu, Michael Dark, Missa Sanou, Shannon Roff, Mobeen Rathore & Janet Yamamoto. (2019) Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. Viruses 11:2, pages 136.
Crossref
Crossref
Wim Jiskoot, Gideon F. A. Kersten, Enrico Mastrobattista & Bram Slütter. 2019. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
281
304
.
Noah Kiwanuka, Juliet Mpendo, Stephen Asiimwe, Julius Ssempiira, Annet Nalutaaya, Betty Nambuusi, Mathias Wambuzi, Brian Kabuubi, Annemarie Namuniina, Frederick Oporia, Annet Nanvubya & Ali Ssetaala. (2018) A randomized trial to assess retention rates using mobile phone reminders versus physical contact tracing in a potential HIV vaccine efficacy population of fishing communities around Lake Victoria, Uganda. BMC Infectious Diseases 18:1.
Crossref
Crossref
Joshua Pankrac, Katja Klein, Paul F. McKay, Deborah F. L. King, Katie Bain, Jason Knapp, Tsigereda Biru, Chanuka N. Wijewardhana, Rahul Pawa, David H. Canaday, Yong Gao, Sarah Fidler, Robin J. Shattock, Eric J. Arts & Jamie F. S. Mann. (2018) A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system. npj Vaccines 3:1.
Crossref
Crossref
Peter Hraber, Cecilia Rademeyer, Carolyn Williamson, Michael S. Seaman, Raphael Gottardo, Haili Tang, Kelli Greene, Hongmei Gao, Celia LaBranche, John R. Mascola, Lynn Morris, David C. Montefiori & Bette Korber. (2017) Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments. Journal of Virology 91:19.
Crossref
Crossref